Inhibitor of p38 MAP kinase
US9624196B2 · kind B2 · utility
15Cited by
28References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 31, 2016 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | Aug 31, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (XV):wherein R1 represents an amino group, a protected amino group or nitro group; or a salt thereof. The compound is a p38 MAP kinase inhibitor. The compound and its pharmaceutically acceptable salts can be used for treatment of conditions, such as inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.